Neurogram
PrivateLast Round
Seed
Jul 31, 2025
Total Funding Raised
$4.4M
Company Overview
Neurogram operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Seed round in July 2025.
Neurogram is a healthtech company that provides a comprehensive electroencephalogram management platform designed to assist neurological diagnosis with advanced tools, enhancing the medical routine with agility and precision.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurogram Comparables
Compare Neurogram with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piramidal | 81% | |
| LVIS Corporation | 79% | |
| Persyst Development Corporation | 77% |
For institutional investors. Book with your work email.
Neurogram Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 31, 2025 | ||||
| Pre Seed | Nov 23, 2023 |
For institutional investors. Book with your work email.
Neurogram Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Starship Ventures | Seed, Pre Seed |
| Google for Startups Accelerator | Seed |
| Contrarian Ventures | Seed |
| Dorm Room Fund | Seed, Pre Seed |
| Headline | Seed |
| Fusen Fund | Seed, Pre Seed |
| Caffeinated Capital | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
Grew 32% QoQ from 19 to 25 employees.
- Nov 15, 2025
Grew 21% QoQ from 19 to 23 employees.
For institutional investors. Book with your work email.
Neurogram Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurogram's valuation, stock price, and market status.
Is Neurogram a public or private company?
Neurogram is a private company.
What is the current stock price of Neurogram?
Neurogram is a private company, so its shares have no public market price. Caplight tracks Neurogram's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurogram worth (valuation)?
Valuation information for Neurogram is not publicly available.
Can I buy Neurogram stock?
Neurogram shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurogram's last funding round?
Neurogram's most recent funding round was Seed on July 31, 2025.
Who are the main investors in Neurogram?
Key investors in Neurogram include Headline.
Will Neurogram IPO soon?
No public IPO plans have been announced for Neurogram.
How can I track Neurogram secondary market activity?
Caplight tracks bids, offers, and trades in Neurogram's shares on secondary markets.